Molecular Data Inc
NASDAQ:MKD
Molecular Data Inc
Total Liabilities & Equity
Molecular Data Inc
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Molecular Data Inc
NASDAQ:MKD
|
Total Liabilities & Equity
¥684.8m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Total Liabilities & Equity
¥1.8T
|
CAGR 3-Years
1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
32%
|
|
Pinduoduo Inc
NASDAQ:PDD
|
Total Liabilities & Equity
¥348.1B
|
CAGR 3-Years
30%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
JD Health International Inc
HKEX:6618
|
Total Liabilities & Equity
¥61.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
120%
|
CAGR 10-Years
N/A
|
|
Meituan
HKEX:3690
|
Total Liabilities & Equity
¥293B
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
JD.Com Inc
HKEX:9618
|
Total Liabilities & Equity
¥601.8B
|
CAGR 3-Years
13%
|
CAGR 5-Years
23%
|
CAGR 10-Years
37%
|
See Also
What is Molecular Data Inc's Total Liabilities & Equity?
Total Liabilities & Equity
684.8m
CNY
Based on the financial report for Dec 31, 2020, Molecular Data Inc's Total Liabilities & Equity amounts to 684.8m CNY.
What is Molecular Data Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
22%
Over the last year, the Total Liabilities & Equity growth was 39%. The average annual Total Liabilities & Equity growth rates for Molecular Data Inc have been 22% over the past three years .